Recent FTC Warning Letters Target CBD Medical Claims

September 10, 2019, the U.S. Federal Trade Commission (“FTC”) issued a news release announcing the recent distribution of warning letters to three companies advertising cannabidiol (“CBD”) products as a medical treatment option for a range of various illnesses. Cautioning that such unsubstantiated … Read more about Recent FTC Warning Letters Target CBD Medical Claims

Proposed California CBD Bill Suspended

Contrary to the bill’s projected outcome from earlier in the summer, California lawmakers will not make a decision on Assembly Bill-228 (“AB 228”) this year as the bill has stalled in the state legislature despite broad bipartisan interest and consumer support. Previously expected to be signed into … Read more about Proposed California CBD Bill Suspended

FDA Plans Release of CBD Regulations by Fall 2019

Cannabidiol (“CBD”) products have gained popularity across the country, but clear regulation from the Food and Drug Administration (“FDA”) is still forthcoming. This July, FDA announced an intent to fast- track the process to create these much-needed regulations. Currently, nearly 90% of CBD … Read more about FDA Plans Release of CBD Regulations by Fall 2019

Revisiting the War on Drugs & Its Impact

July 14 marked the 50th anniversary of President Richard Nixon’s message to Congress asking for the establishment of a federal plan to tackle substance abuse, citing a dramatic increase in juvenile arrests for drug offenses. Nixon’s letter was the start of a new era of American drug policy as, the … Read more about Revisiting the War on Drugs & Its Impact

New Data Projects Decrease in CBD Prices

Cannabidiol (“CBD”) products have garnered unprecedented levels of market interest following the Agriculture Improvement Act of 2018 (“2018 Farm Bill”). Indeed, even though the Food and Drug Administration (“FDA”) still considers ingestible CBD consumer products to be prohibited – the drug Epidiolex … Read more about New Data Projects Decrease in CBD Prices

NFL Announces Research into Cannabis Pain Management

This month, the National Football League (“NFL”) announced that it, along with the National Football League Players Association (“NFLPA”), will be investigating the medicinal potential of cannabis and cannabinoids – such as cannabidiol (“CBD”) - as alternative pain management treatments. In the … Read more about NFL Announces Research into Cannabis Pain Management

FDA Plans Public Hearing on Ingestible CBD Products

Last Wednesday, at a hearing held by the House Appropriations Committee, U.S. Food and Drug Administration (“FDA”) Commissioner Scott Gottlieb revealed the FDA’s plan to conduct public hearings on cannabidiol (“CBD”) starting in April. Acknowledging the legalization of hemp and hemp-derived products … Read more about FDA Plans Public Hearing on Ingestible CBD Products

The Agricultural Improvement Act of 2018 & Federal Trademarks

Securing federal trademark protection for products derived from industrial hemp has proven to be a challenge for many in the industry. The United States Patent and Trademark Office (the “USPTO) categorically denies any trademark application that is submitted for an “illegal” product or service.1 Up … Read more about The Agricultural Improvement Act of 2018 & Federal Trademarks